Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease

NCT00376714 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GSK233705

Sponsor

GlaxoSmithKline